Table 2 Predictions of interleukin-17
From: Is serum Interleukin-17 associated with early atherosclerosis in obese patients?
Coefficient | Std. error | 95% CI | t | P | |
|---|---|---|---|---|---|
Il-17/WC | −0.073 | 1.17 | −2.40 to 2.26 | −0.062 | 0.95 |
Il-17/BMI | 2.83 | 2.03 | −1.21 to 6.89 | 1.39 | 0.16 |
Il-17/WHR | 338.62 | 314.13 | −286.7 to 964.01 | 0.28 | 0.28 |
Il-17 SAT | 5.64 | 21.47 | −37.10 to 48.39 | 0.26 | 0.79 |
Il-17/VAT | 5.97 | 6.46 | −6.89 to 18.83 | 0.92 | 0.35 |
Il-17/Fibrinogen | 0.34 | 0.21 | −0.087 to 0.77 | 1.58 | 0.11 |
Il-17/CRP | 2.18 | 7.61 | −12.97 to 17.33 | 0.28 | 0.77 |
Il-17/SLD | −6.54 | 10.58 | −27.61 to 14.52 | −0.61 | 0.53 |
Il-17/Ferritin | −0.10 | 0.12 | −0.34 to 0.13 | −0.84 | 0.4 |
Il-17/TNF-α | 1.08 | 0.067 | 0.94 to 1.21 | 15.9 | <0.0001 |
Il-17/IL-6 | 5.15 | 0.63 | 3.89 to 6.42 | 8.1 | <0.0001 |
Il-17/IFN- γ | 0.44 | 0.024 | 0.39 to 0.49 | 18.0 | <0.0001 |
Il-17/US | 9.71 | 27.96 | −45.96 to 65.39 | 0.34 | 0.72 |
Il-17/ALT | −0.71 | 1.02 | −2.75 to 1.31 | −0.70 | 0.48 |
Il-17/CHE | 0.012 | 0.008 | −0.03 to 0.004 | −1.47 | 0.14 |
Il-17/AP | 0.006 | 0.62 | −1.24 to 1.25 | 0.009 | 0.99 |
Il-17/γ-GT | 0.049 | 0.81 | −1.56 to 1.66 | 0.061 | 0.95 |
Il-17 /IL-8 | 1.73 | 0.086 | 1.55 to 1.90 | 20.01 | <0.0001 |
Il-17/CXCL10/IP-10 | 0.0032 | 0.036 | −0.069 to 0.076 | 0.087 | 0.93 |
Il-17/CCL4/MIP1β | 3.43 | 0.45 | 2.53 to 4.33 | 7.6 | <0.0001 |
Il-17/Eotaxin | 0.78 | 0.16 | 0.45 to 1.11 | 4.73 | <0.0001 |
Il-17/HDL | 0.64 | 1.39 | −3.42 to 2.13 | −0.46 | 0.6460 |
Il-17/LDL | 0.12 | 0.17 | −0.21 to 0.45 | 0.7 | 0.48 |
Il-17/HOMA | 0.13 | 4.22 | −8.26 to 8.54 | 0.032 | 0.97 |
Il-17/Triglycerides | 0.12 | 0.18 | −0.23 to 0.48 | 0.69 | 0.48 |
Il-17/IMT | 275.0 | 485.7 | −691.95 to 1241.96 | 0.56 | 0.57 |
Il-17/SBP | 0.17 | 0.43 | −0.68 to 1.03 | 0.41 | 0.68 |
Il-17/DBP | −0.35 | 1.99 | −4.32 to 3.60 | −0.17 | 0.85 |
Il-17/RMR | 0.0058 | 0.038 | −0.070 to 0.081 | 0.15 | 0.87 |
Il-17/ImTG | 14.80 | 17.45 | −19.94 to 49.5 | 0.84 | 0.39 |